Pathologizing means treating a normal human experience, behavior, or trait as if it were a medical problem. When something gets pathologized, it shifts from being seen as a natural part of life to being classified as a disorder, disease, or dysfunction that needs treatment. The term is most often used in psychology and psychiatry, but it shows up in broader conversations about health, identity, and social issues.
The word carries a critical edge. People usually say something “has been pathologized” when they believe the label of illness was applied where it doesn’t belong, turning ordinary sadness into clinical depression, for instance, or framing shyness as social anxiety disorder. Understanding how this process works helps explain some of the biggest shifts in how medicine and society think about what counts as “normal.”
How Behaviors Become Disorders
The formal process of pathologization happens through diagnostic manuals. In psychiatry, the main reference is the Diagnostic and Statistical Manual of Mental Disorders (DSM), published by the American Psychiatric Association. The World Health Organization maintains a parallel system called the International Classification of Diseases (ICD). These manuals define the line between a normal experience and a diagnosable condition, and they are revised regularly based on evolving research and expert consensus.
That line is often drawn on pragmatic grounds. A pattern of behavior typically gets classified as a disorder when it causes significant distress, impairs someone’s ability to function in daily life, or predicts a meaningful response to treatment. But critics point out a circular logic here: a condition can effectively become a mental disorder simply because an effective treatment exists for it. The boundary between “healthy variation” and “clinical problem” is not as clean or objective as it might seem.
Homosexuality: The Textbook Example
No case illustrates pathologization and its reversal more clearly than homosexuality. Until 1973, the DSM listed homosexuality as a mental disorder. That year, psychiatrist Robert Spitzer led a review of every condition in the manual and concluded that, unlike other listed disorders, homosexuality did not regularly cause subjective distress or impair social functioning. In December 1973, the APA’s Board of Trustees voted to remove it.
The decision was not unanimous. Psychoanalytic psychiatrists objected and forced a vote of the full APA membership. The removal was upheld by a 58% majority of roughly 10,000 voting members. The episode revealed that diagnostic categories are not purely scientific discoveries. They reflect the values, assumptions, and social context of the people who write them. A behavior that was “sick” in 1972 was officially normal by 1974, not because gay people changed, but because the profession’s understanding did.
Gender Identity and Global Reclassification
A similar shift happened more recently with gender identity. In the ICD-10, the WHO’s previous classification system, being transgender was listed under “Mental and behavioural disorders” with labels like “transsexualism” and “gender identity disorder of children.” The updated ICD-11 replaced those terms with “gender incongruence” and moved the category entirely out of the mental health chapter into a new chapter called “Conditions related to sexual health.”
The WHO was explicit about why: trans and gender-diverse identities are not conditions of mental ill health, and classifying them as such causes enormous stigma. At the same time, keeping a diagnostic code in the system was a deliberate choice. Without one, transgender people could lose access to gender-affirming health care and insurance coverage. This tension, between removing a stigmatizing label and preserving access to care, sits at the heart of nearly every pathologization debate.
Grief as the Latest Battleground
The most recent controversy involves grief. The DSM-5-TR added a new diagnosis called Prolonged Grief Disorder, applied when someone experiences intense, disabling grief for at least 12 months after a death (six months for children and adolescents), with symptoms occurring nearly every day for the preceding month.
Critics have raised three main concerns. First, the research behind the diagnosis has followed a nonlinear path, raising questions about how reliably the criteria can be applied across different populations. Second, there is a significant gap in the evidence distinguishing prolonged grief disorder from normal, if painful, mourning. Third, putting grief in a diagnostic manual opens the door to pharmaceutical treatment of a universal human experience, along with the stigma that comes with a psychiatric label. Supporters counter that some people genuinely get stuck in grief that destroys their ability to live, and a formal diagnosis gives them access to targeted help.
When Labels Help and When They Harm
Pathologizing is not always a bad thing. A diagnosis can be genuinely useful. It gives clinicians a shared language to communicate about treatment, helps researchers study patterns across large populations, and in many healthcare systems, it is the only way to unlock insurance coverage or disability benefits. For someone struggling with a condition that has a name and a known treatment path, a diagnosis can feel like validation rather than stigma.
But diagnostic labels also carry real psychological costs. Research on depression has found that stigma is associated with lower intentions to seek help, delays in getting treatment, reluctance to disclose symptoms to family members or doctors, poorer treatment adherence, and worse outcomes overall. Stigma functions as a form of social exclusion. The sociologist Erving Goffman described it as a mark that converts someone from a “usual person” to one seen as tainted, leading to rejection, avoidance, and distancing. One study found that patients whose depression was managed primarily through medication actually reported increased stigma concerns compared to those in other treatment settings, suggesting that the medical framing itself can reinforce feelings of being “broken.”
Pathologizing Poverty
Some of the most striking examples of pathologization have nothing to do with mental health in the traditional sense. After welfare reform in the United States dismantled many direct financial assistance programs, low-income people increasingly had to obtain a psychiatric diagnosis to qualify for disability payments through Supplemental Security Income (SSI). By 1999, psychiatric diagnoses had become the single largest category qualifying people for SSI benefits, and that share has continued to grow.
The consequences are concrete and troubling. People living in poverty who might otherwise identify as capable workers are pressured to adopt identities as permanently disabled. In some cases, continued receipt of benefits requires taking antipsychotic medications, drugs that carry risks of obesity, diabetes, and high cholesterol, even when the person’s core problem is economic rather than psychiatric. Researchers have documented cases of individuals who were prescribed antipsychotics not primarily to treat symptoms but to establish and maintain a diagnosis that would keep their benefits and housing intact. As Marcia Angell, a former editor of the New England Journal of Medicine, put it: for many low-income families facing economic hardship, applying for SSI based on mental disability has become the only way to survive.
This dynamic is what researchers call “the pathologization of poverty.” It turns a social and economic problem into an individual medical one, forcing people to become patients in order to access basic resources.
The Neurodiversity Perspective
A growing challenge to pathologization comes from the neurodiversity movement, which reframes conditions like autism and ADHD. The traditional medical model focuses on diagnosis: identifying what a person cannot do, cataloging deficits, and treating them. The neurodiversity framework, increasingly adopted in clinical settings, uses a strengths-based model instead. It focuses on what a neurodiverse person can do and asks how environments can be adapted to support different ways of thinking, rather than assuming the person needs to be fixed.
This does not mean ignoring genuine struggles. Many people with ADHD or autism experience real difficulties that benefit from support and accommodation. The shift is in framing: instead of asking “what is wrong with this person,” the question becomes “what does this person need to thrive.” Stanford Medicine has highlighted this approach as a meaningful change in how providers understand and care for neurodiverse patients, moving the focus from pathology to fit.
Why the Distinction Matters
Pathologizing is worth understanding because it shapes how people see themselves and how society treats them. When a behavior is labeled a disorder, it changes everything downstream: how doctors respond, what insurance covers, how families react, whether someone feels broken or simply different. The line between “this person has a medical condition” and “this person has been pathologized” often comes down to whether the label serves the individual or mainly serves the system around them. Recognizing that line is not always obvious is the first step toward thinking critically about it.